When to Combine Endocrine Therapy With a New Agent for Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women

被引：0
|
作者：
Seidman, Andrew D. [1 ,2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Weill Cornell Med Coll, New York, NY USA
来源：
ONCOLOGY-NEW YORK | 2016年 / 30卷 / 03期
关键词：
MONOTHERAPY; PALBOCICLIB;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：224 / 228
页数：5
相关论文
共 50 条
  • [21] Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer
    Sharvina Ziyeh
    Lauren Wong
    Reva K. Basho
    Current Oncology Reports, 2023, 25 : 689 - 698
  • [22] Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer
    Ziyeh, Sharvina
    Wong, Lauren
    Basho, Reva K.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (07) : 689 - 698
  • [23] Are we there yet? Optimal duration of endocrine therapy in women with postmenopausal early-stage hormone receptor-positive breast cancer
    Symonds, Lynn K.
    Davidson, Nancy E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (11): : 1240 - 1242
  • [24] Surgery Should Complement Endocrine Therapy for Elderly Postmenopausal Women with Hormone Receptor-Positive Early-Stage Breast Cancer
    Nguyen, Olivier
    Sideris, Lucas
    Drolet, Pierre
    Gagnon, Marie-Claude
    Leblanc, Guy
    Leclerc, Yves E.
    Mitchell, Andrew
    Dube, Pierre
    INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY, 2012, 2012
  • [25] Fulvestrant: A guide to its use in hormone receptor-positive metastatic breast cancer in postmenopausal women in the EU
    Scott L.J.
    Croxtall J.D.
    McKeage K.
    Drugs & Therapy Perspectives, 2014, 30 (2) : 42 - 47
  • [26] FulvestrantA Review of its Use in the Management of Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women
    Jamie D. Croxtall
    Kate McKeage
    Drugs, 2011, 71 : 363 - 380
  • [27] Fulvestrant A Review of its Use in the Management of Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women
    Croxtall, Jamie D.
    McKeage, Kate
    DRUGS, 2011, 71 (03) : 363 - 380
  • [28] Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer
    Beomyoung Cho
    Maria Pérez
    Donna B. Jeffe
    Matthew W. Kreuter
    Julie A. Margenthaler
    Graham A. Colditz
    Ying Liu
    BMC Cancer, 22
  • [29] Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer
    Cho, Beomyoung
    Perez, Maria
    Jeffe, Donna B.
    Kreuter, Matthew W.
    Margenthaler, Julie A.
    Colditz, Graham A.
    Liu, Ying
    BMC CANCER, 2022, 22 (01)
  • [30] Postmenopausal Hormone Receptor-Positive Advanced Breast Cancer
    Connolly, Roisin M.
    Stearns, Vered
    ONCOLOGY-NEW YORK, 2013, 27 (06): : 571 - +
12345